CAMC Health System
CAMC Health System sponsors 28 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 17 completed. 5 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Interventional Radiology, with 2 trials.
Trial Pipeline
28 total, page 1 of 1
Prospective IR-led Sedation Feasibility
NCT07443254
Statin and Beta Blocker Use in Patients With Decompensated Cirrhosis
NCT06764966
Single-Center Prospective Study to Investigate the Difference in the Incidence of Contrast-Induced Nephropathy in High-Risk Patients With the Use of the Dye-Vert Plus System
NCT04279457
Evaluation of Ketamine/Midazolam Sedation vs. Fentanyl/Midazolam Sedation for Image-Guided Percutaneous Procedures in Interventional Radiology
NCT07040163
Pregabalin vs. Gabapentin on Reducing Opioid Usage
NCT04705480
Pain Control in Pediatric Oncology: Utility of EMLA Cream vs Lidocaine Injection in Lumbar Punctures
NCT04003012
Resting Energy Expenditure in Patients With Cystic Fibrosis: A Pilot Study
NCT03699982
Intravenous Lidocaine for Cystectomy Procedures
NCT02924480
Procalcitonin Levels as a Predictor of Bacteremia in Febrile Pediatric Oncology Patients-Pilot Study
NCT02417168
Effect of Infant Immunization on Procalcitonin Levels - A Pilot Study
NCT04295694
A Multidisciplinary Approach to Vocal Cord Dysfunction: A Novel Pilot Study
NCT01916616
Ultrasound Versus Fluoroscopically-guided Arterial Access in Non-cardiac Vascular Patients
NCT01612026
The Role of ImmuKnow® in the Management of Immunosuppressants in the Renal Transplant Patient
NCT01424345
Effect of Magnesium Sulfate Infusion Rate on Magnesium Retention in Critically Ill Patients
NCT01426165
Can Neck Circumference Measurements Less Than 43cm or Greater Than 43cm Predict Difficulty of Tracheal Intubation?
NCT01191658
Trial Comparison of Accuseal and Bovine Pericardial Patch During Endarterectomy
NCT01184183
Phospholipase A2 Producing Bacteria and Pre-Term Labor
NCT00855543
Ureteral Stent Size Measurement Study
NCT00919386
Osteopathic Manipulation Therapy in the Treatment of Interstitial Cystitis
NCT00873171
Percutaneous Nephrolithotomy Versus Extracorporeal Shock Wave Lithotripsy
NCT00873054
Study of the Effect of Neck Treatment on Shoulder Impingement
NCT00764764
Correlation of Cerebral State Index With the Richmond Agitation-Sedation Scale in Mechanically Ventilated ICU Patients
NCT00855075
Weekly Phone Calls Versus Brief Patient Education to Improve Continuous Positive Airway Pressure (CPAP) Compliance
NCT00945776
Vancomycin and Daptomycin Plus Cefazolin for Preoperative Vascular Surgery Prophylaxis
NCT00967941
Enteral Naloxone Versus a Traditional Bowel Regimen for the Prevention of Opioid Induced Constipation in Trauma Patients
NCT00799201
Selective Versus Routine Shunting in Carotid Endarterectomy Patients
NCT00967486
A Pilot Study to Determine the Efficacy of a Low Carbohydrate Diet in Treatment of Adolescents With Metabolic Syndrome
NCT00940966
Education Program for Family Caregivers
NCT00764647
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 2 |
| Phase 4 | 5 |
What the Pipeline for CAMC Health System Shows
According to the ClinicalTrials.gov registry, CAMC Health System is linked to 28 US clinical trials across every stage of research activity. Of those, 3 studies are currently recruiting, about 11% of the sponsor's indexed portfolio, and 17 are already marked complete, representing roughly 61% of the total.
The phase mix for CAMC Health System reports 5 late-stage studies (Phase 3 and Phase 4 combined) and 5 earlier-phase studies (Phase 1 and Phase 2).
The top therapeutic focus area indexed for CAMC Health System is Interventional Radiology with 2 linked trials, and 9 other condition areas appear in the top list above.
How to read these pipeline numbers
Recruiting share is one of the more practical signals here: it reflects how much of a sponsor's research is presently open to new participants, while the completed share indicates the depth of finished work that has already contributed registry results. Both counts come directly from the public ClinicalTrials.gov dataset and are refreshed on the registry side; this page mirrors the latest data pull without altering it.
A portfolio weighted toward Phase 3 usually reflects an organization advancing candidates toward regulatory review, where the research centers on comparative efficacy and broader safety across larger populations. A heavier Phase 1 and Phase 2 tilt generally indicates exploratory work, safety, dosing, and early signal detection, and is common among research-forward sponsors that seed many early programs. Phase 4 entries, when present, track interventions already in real-world use and typically focus on long-term safety, effectiveness across subgroups, or formulation comparisons.
That distribution is a quick read of where the organization concentrates its research attention; it does not imply product availability, market share, or any clinical endorsement. All numbers on this page come from ClinicalTrials.gov maintained by the National Library of Medicine, and counts can shift as new studies are registered or existing ones update their status. This information is provided for reference and educational purposes only, not as medical, investment, or regulatory advice, verify current details directly with ClinicalTrials.gov before relying on any figure here.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.